Neurotech
Saving Sight Through Biotechnology | Neurotech Pharmaceuticals.
Launch date
Employees
Market cap
-
Enterprise valuation
CAD191—286m (Dealroom.co estimates Nov 2006.)
Cumberland Rhode Island (HQ)
| Date | Investors | Amount | Round |
|---|---|---|---|
| - | N/A | - | |
€12.0m | Late VC | ||
$35.0m | Series B | ||
| Total Funding | CAD65.7m | ||
Related Content
Recent News about Neurotech
EditTech stack
Tech stackLearn more about the technologies and tools that this company uses.